David Platt - Dec 31, 2021 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role: CEO, Director, 10%+ Owner
Signature: /s/ David Platt
Stock symbol: BIXT
Transactions as of: Dec 31, 2021
Transactions value $: $47,501
Form type: 5
Date filed: 1/28/2022, 01:14 PM
Previous filing: Jan 18, 2022
Next filing: May 13, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIXT	Common	Award	$54.7K	+228K	+0.52%	$0.24	43.7M	Jan 15, 2021	Direct
transaction	BIXT	Common	Award	$387K	+2.97M	+6.81%	$0.13	46.6M	Jun 4, 2021	Direct
transaction	BIXT	Common	Gift	-$442K	-3.2M	-6.86%	$0.14	43.4M	Nov 19, 2021	Direct	F1
transaction	BIXT	Common	Award	$4.14K	+2.07M	+4.76%	$0.00^*	45.5M	Dec 3, 2021	by NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIXT	Warrants	Award	$43.9K	+122K		$0.36	122K	May 2, 2021	Common	122K	$2.00	by NDPD Pharma, Inc.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares returned to Company's treasury
F2	The warrant agreement includes provisions for dilutive issuance and cash-less exercise